Overview
- China’s National Development and Reform Commission cautioned that a surge of similar humanoid prototypes risks diverting talent from substantive research, according to spokeswoman Li Chao.
- Policy signals include expanded funding for core R&D and the creation of national facilities for testing and training robots to improve measurable capabilities.
- Regulators plan formal market entry and exit rules and support for consolidation and resource sharing to curb low‑quality duplication and overcapacity.
- Investor interest remains strong, with the Solactive China Humanoid Robotics Index up nearly 30% this year and UBTech shares rising more than 4% on Friday.
- The boom followed Unitree’s high‑profile Spring Festival Gala performance, even as large‑scale household or factory deployment is still viewed as years away.